Do some research; it’s not that difficult. While I appreciate that a more in-depth analysis can be useful to some, it also encourages others to remain lazy. To save you some time, Ultromics (EchoGo®) is clearly the front-runner. While you're at it, read the FDA statement below, which clearly indicates that EIQ's approval was predicated on the existence of similar technologies.
See FDA letter here. David Playford on LinkedIn: #echocardiography | 14 comments
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $148.3M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 23.0¢ | $139.8K | 606.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 772241 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 176250 | 4 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |